Drug Shortage Report for NORDITROPIN NORDIFLEX
Report ID | 178319 |
Drug Identification Number | 02334852 |
Brand name | NORDITROPIN NORDIFLEX |
Common or Proper name | NORDITROPIN NORDIFLEX |
Company Name | NOVO NORDISK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | SOMATROPIN |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | EA |
ATC code | H01AC |
ATC description | ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2023-06-01 |
Actual start date | 2023-06-08 |
Estimated end date | 2023-08-30 |
Actual end date | 2023-08-31 |
Shortage status | Resolved |
Updated date | 2023-09-01 |
Company comments | Norditropin® FlexPro™ will be available for impacted 5 mg patients to transition to. For any questions or concerns, please contact our Customer Care at 1-800-465 4334. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2023-09-01 | English | Compare |
v10 | 2023-08-31 | French | Compare |
v9 | 2023-08-31 | English | Compare |
v8 | 2023-06-14 | French | Compare |
v7 | 2023-06-14 | English | Compare |
v6 | 2023-06-09 | English | Compare |
v5 | 2023-06-08 | French | Compare |
v4 | 2023-06-08 | English | Compare |
v3 | 2023-06-02 | English | Compare |
v2 | 2022-12-14 | French | Compare |
v1 | 2022-12-14 | English | Compare |
Showing 1 to 11 of 11